Most books discuss general and broad topics regarding molecular imagings. However, Ultrasmall Lanthanide Oxide Nanoparticles for Biomedical Imaging and Therapy, will mainly focus on lanthanide oxide nanoparticles for molecular imaging and therapeutics. Multi-modal imaging capabilities will discussed, along with up-converting FI by using lanthanide oxide nanoparticles. The synthesis will cover polyol synthesis of lanthanide oxide nanoparticles, Surface coatings with biocompatible and hydrophilic ligands will be discussed and TEM images and dynamic light scattering (DLS) patterns will be provided. Various techniques which are generally used in analyzing the synthesized surface coated nanoparticles will be explored and this section will also cover FT, IR analysis, XRD analysis, SQUID analysis, cytotoxicity measurements and proton relaxivity measurements. In vivo MR images, CT images, fluorescence images will be provided and Therapeutic application of gadolinium oxide nanoparticles will be discussed. Finally, future perpectives will be discussed. That is, present status and future works needed for clinical applications of lanthanide oxide nanoparticles to molecular imagings will be discussed.
- Synthesis will be discussed in detail
- General characterizations of nanoparticles before in vivo applications will be discussed
- The book will cover all possible applications of lanthanide oxide nanoparticles to molecular imagings such as MRI, CT, FI as well as therapeutics
Gang Ho Lee is a professor in the Department of Chemistry at the College of Natural Sciences, Kyungpook National University, Teagu, South Korea.
Most books discuss general and broad topics regarding molecular imagings. However, Ultrasmall Lanthanide Oxide Nanoparticles for Biomedical Imaging and Therapy, will mainly focus on lanthanide oxide nanoparticles for molecular imaging and therapeutics. Multi-modal imaging capabilities will discussed, along with up-converting FI by using lanthanide oxide nanoparticles. The synthesis will cover polyol synthesis of lanthanide oxide nanoparticles, Surface coatings with biocompatible and hydrophilic ligands will be discussed and TEM images and dynamic light scattering (DLS) patterns will be provided. Various techniques which are generally used in analyzing the synthesized surface coated nanoparticles will be explored and this section will also cover FT, IR analysis, XRD analysis, SQUID analysis, cytotoxicity measurements and proton relaxivity measurements. In vivo MR images, CT images, fluorescence images will be provided and Therapeutic application of gadolinium oxide nanoparticles will be discussed. Finally, future perpectives will be discussed. That is, present status and future works needed for clinical applications of lanthanide oxide nanoparticles to molecular imagings will be discussed. Synthesis will be discussed in detail General characterizations of nanoparticles before in vivo applications will be discussed The book will cover all possible applications of lanthanide oxide nanoparticles to molecular imagings such as MRI, CT, FI as well as therapeutics
Cover 1
Ultrasmall lanthanide oxide nanoparticles for biomedical imaging and therapy 4
Copyright 5
Dedication 6
Contents 8
List of figures and tables 12
List of abbrevations 16
Acknowledgments 20
Preface 22
About the authors 24
1 Introduction to biomedical imaging 26
1.1 What is biomedical imaging? 26
1.2 Various imaging modalities now available 27
1.3 References 36
2 Properties and possible application areas 40
2.1 Introduction 40
2.2 Possible application areas 50
2.3 References 51
3 Synthesis and surface modification 54
3.1 Synthesis 54
3.2 Surface coating 57
3.3 Other lanthanide nanosystems 60
3.4 References 62
4 Characterization 68
4.1 Introduction 68
4.2 Particle diameter and morphology 69
4.3 Crystal structure 72
4.4 Hydrodynamic diameter 74
4.5 Surface coating confirmation 76
4.6 Surface coating amount 77
4.7 Magnetic properties 79
4.8 Cytotoxicity 82
4.9 Water proton relaxivity and map image 85
4.10 Biodistribution 87
4.11 In vivo TEM analysis of nanoparticles 88
4.12 Fluorescent properties 88
4.13 References 89
5 MRI, CT, FI, and multimodal imaging and images 94
5.1 Magnetic resonance imaging (MRI) and images 95
5.2 X-ray computed tomography (CT) and images 100
5.3 Fluorescent imaging (FI) and images 102
5.4 Multimodal imaging 104
5.5 References 106
6 A simple model calculation of water proton relaxivities 110
6.1 Introduction 110
6.2 Magnetization 111
6.3 Longitudinal water proton relaxation (T1) and relaxivity (r1) 114
6.4 Transverse water proton relaxation (T2) and
117
6.5 Concluding remarks 119
6.6 References 119
7 Thermal neutron capture therapy (NCT) 122
7.1 Introduction 122
7.2 BNCT 125
7.3 GdNCT 125
7.4 References 127
8 Perspectives and challenges 128
8.1 Perspectives and challenges 128
8.2 What needs to be done for clinical applications 130
Index 132
Introduction to biomedical imaging
Abstract
This chapter defines biomedical imaging and briefly introduces various imaging modalities and imaging agents. These include magnetic resonance imaging (MRI), X-ray computed tomography (CT), ultrasound imaging (USI), positron emission tomography (PET), single photon emission computed tomography (SPECT), fluorescent imaging (FI), and corresponding imaging agents.
Key words
biomedical imaging
MRI
CT
USI
PET
SPECT
FI
imaging agents
1.1 What is biomedical imaging?
Biomedical imaging is an area that visually characterizes living objects in vitro and in vivo such as cells, tissues, and organs in the human body through various spectroscopic techniques. Functional, biological, and metabolic processes can also be investigated. Nowadays biomedical imaging is an essential tool to diagnose and treat diseases such as cancer, and a variety of biomedical imaging modalities are now available. These include magnetic resonance imaging (MRI), X-ray computed tomography (CT), ultrasound imaging (USI), positron emission tomography (PET), single photon emission computed tomography (SPECT), and fluorescent imaging (FI). The operation of biomedical imaging critically depends on the imaging agent. In MRI, CT, and USI, images are improved with an imaging agent through contrast enhancement. In PET, SPECT, and FI, imaging agents are essential components in obtaining clear images.
Biomedical imaging rapidly developed in both imaging tools and imaging agents. As a result, both resolution and sensitivity have been improved. In addition, multi-imaging modalities, such as MRI-CT and MRI-PET, are now being developed. They can provide us with complementary information and some of them are already available in the market. Sensitivity is further improved by integration of a targeting molecule into the imaging agent. A drug can be conjugated to an imaging agent for both diagnosis and treatment (so-called theragnosis) of diseases such as cancer.
1.2 Various imaging modalities now available
It is worth briefly introducing some imaging modalities and imaging agents that are now available. Ultrasmall lanthanide oxide nanoparticles can be used in various imaging modalities, including MRI, CT, USI, PET, SPECT, and FI. USI costs are low and so is the most frequently used to check health and diagnose disease. CT and MRI are more expensive than USI and so are less frequently used. PET and SPECT are the most expensive and least frequently used, mainly due to radio-isotopes being used as imaging agents. FI is very sensitive but mostly used for research purposes owing to its imaging depth limits. Each one of these imaging techniques is described below.
1.2.1 Ultrasound imaging (USI)
Ultrasound imaging is a truly non-invasive imaging modality because it makes use of non-ionizing ultrasonic radiation [1]. Therefore, it does not harm the human body. The frequency in USI ranges from 2 to 18 MHz. The ultrasound wave is generated by a piezoelectric transducer (PZT) and travels through the body, where it can be focused to the desired depth for imaging. The returning ultrasound wave (i.e. the echo) to the tranducer is transformed into an electrical signal and finally into an image.
The ultrasound image can be improved by using contrast agents through echo signal enhancement [2,3]. The currently used USI contrast agents are microbubbles, which contain air or a specific gas such as nitrogen and perfluorocarbon in a lipid, galactose, polymer, or albumin shell. These microbubbles range from 1 to 5 μm in diameter. A USI contrast agent is intravenously injected into the body. When an ultrasound wave passes through a microbubble, the gas inside that microbubble compresses and oscillates, reflecting the ultrasound wave and thus enhancing the echo signal. The echo signal can be further enhanced if the ultrasound wave resonates inside the microbubble. Under such conditions, even a small blood vessel can be imaged. If a USI contrast agent is conjugated with a targeting molecule, such as an antibody or a peptide, the echo signal from the targeted region can be further boosted. A USI contrast agent can also be applied to theragnosis if a drug is conjugated with it. Some commercial USI contrast agents are listed in Table 1.1.
Table 1.1
Some of the USI contrast agents in the market
Optison™ | GE Healthcare, USA | albumin | Octafluoropropane |
Levovist® | Scherring, Germany | lipid/galatose | Air |
Definity® | Lantheus Medical Imaging, Inc., USA | lipid | Octafluoropropane |
Albunex® | MBI, USA and Nycomed Imaging AS, Norway | albumin | air |
1.2.2 X-ray imaging and X-ray computed tomography (CT)
X-ray imaging is frequently used to check for the presence of disease during health examinations and is widely used to image bone structure. The energy of X-rays is so high that it corresponds to ionizing radiation. Therefore it is harmful to the human body if exposed to it for a long time and so cannot be considered a truly non-invasive imaging modality. It may damage DNA and so long-time exposure to X-rays should be avoided, especially for infants.
Wilhelm Röntgen discovered the X-ray and first applied it to bone imaging. The image is obtained by targeting a short pulse of hard X-rays (5–100 keV) to a specific part of the body and detecting the outgoing X-ray beam through the body. The image is then produced on a two-dimensional (2-D) photographic film. Thus, X-ray imaging is based on the reduction of the beam as it passes through the body, so the difference in attenuation of the X-ray beam between organs, tissues, and bones produces the contrast and thus an image. As the X-ray is nearly transparent for soft tissues, X-ray imaging is useful for bones and hardened parts such as diseased areas in tissues.
X-ray computed tomography (CT) is a 2-D image made up of slices that are obtained as both the X-ray beam and detector rotate around the body. After a complete rotation, a slice image is constructed with the help of a sophisticated computation using a computer. The X-ray beam and detector are moved along the body axis and another image slice is obtained from this further scan. A 3-dimensional (3-D) image can be constructed from a continuous set of 2-D image slices. Its spatial resolution and sensitivity are comparable to that of MRI.
X-ray and CT images can be improved using a contrast agent, which strongly attenuates the X-ray beam intensity reaching the detector. Therefore, even soft tissues and tiny blood vessels can be imaged at a high resolution. Two types (i.e. oral and intravascular) of contrast agents are in the market (Table 1.2). The intravascular contrast agents are mostly tri-iodinated organic compounds with hydrophilic functional groups for water-solubility [4,5]. The oral contrast agents are mainly used for imaging stomach and intestines. Improved images can be obtained if a contrast agent is conjugated with a targeting molecule such as an antibody or peptide. On the other hand, gold nanoparticles can provide an enhanced contrast superior to an iodine contrast agent, because gold has an X-ray attenuation power of ∼ 2.7 times that of iodine [6]. Therefore, even the tiniest of blood vessels can be imaged with gold nanoparticles.
Table 1.2
Some of the X-ray (or CT) contrast agents in the market
– | BaSO4 | – | Digestive system |
Omnipaque™ | C19H26I3N3O9 | GE Healthcare, USA | Intravascular |
Visipaque™ | C35H44I6N6O15 | GE Healthcare, USA | Intravascular |
Ultravist® | C18H24I3N3O8 | Bayer Healthcare, Germany | Intravascular |
Isovue® | C17H22I3N3O3 | Bracco, New Zealand | Intravascular |
1.2.3 Magnetic resonance imaging (MRI)
Magnetic resonance imaging (MRI) makes use of nuclear magnetic resonance (NMR) of protons in the body to produce images [7]. It is a truly non-invasive imaging technique, because radiofrequency is used as the radiation source. Due to an ample existence of protons in the body in the form of water, proteins, fats, etc., signal intensity and spatial resolution is better than with USI and comparable to CT. MRI is very useful for imaging soft tissues such as brain, muscles, heart, and so on. Local protons have different densities and relaxation rates, from which images are obtained from differences in contrast. A normal tissue can be differentiated from a cancerous tissue because of their different proton densities and relaxation rates related to angiogenesis.
MRI contrast agents help to improve images through contrast enhancement. There are two types of MRI contrast agents based on proton relaxation mechanisms: T1 and T2 MRI contrast agents. The former is called a positive contrast agent because it makes the contrast brighter...
Erscheint lt. Verlag | 22.11.2014 |
---|---|
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Gesundheitsfachberufe |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Radiologie / Bildgebende Verfahren | |
Medizin / Pharmazie ► Physiotherapie / Ergotherapie ► Orthopädie | |
Technik ► Medizintechnik | |
ISBN-10 | 0-08-100069-3 / 0081000693 |
ISBN-13 | 978-0-08-100069-4 / 9780081000694 |
Haben Sie eine Frage zum Produkt? |
![PDF](/img/icon_pdf_big.jpg)
Größe: 11,2 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
![EPUB](/img/icon_epub_big.jpg)
Größe: 3,6 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich